Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema

Author's Avatar
Mar 23, 2023

RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-VEGF) injections into the eye